Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Application, By End User, By Region and Competition, 2020-2030F

Description

The Global Antimicrobial Susceptibility Testing (AST) Market was valued at USD 4.41 billion in 2024 and is projected to reach USD 5.98 billion by 2030, growing at a CAGR of 5.17% during the forecast period. The market is expanding significantly as antibiotic resistance becomes a pressing global health concern, prompting the need for accurate, timely diagnostic tools. AST plays a pivotal role in guiding clinicians toward appropriate antibiotic treatments, reducing therapy failure rates and curbing the misuse of antimicrobial agents. The growing prevalence of multidrug-resistant infections and the increased global awareness around antimicrobial resistance (AMR) have elevated the demand for reliable AST solutions. Advancements in rapid and automated diagnostic systems are accelerating adoption, particularly in hospitals and diagnostic laboratories. Additionally, integration of AI and machine learning into AST platforms is enhancing precision and efficiency, making AST an essential component of personalized and precision medicine.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 4.41 Billion
Market Size 2030	USD 5.98 Billion
CAGR 2025-2030	5.17%
Fastest Growing Segment	Drug Development
Largest Market	North America

Key Market Drivers

Increase in Prevalence of Infectious Diseases

The rising incidence of infectious diseases, including influenza, tuberculosis, pneumonia, and COVID-19, is significantly driving demand for antimicrobial susceptibility testing. As pathogens evolve and resistance increases, AST has become critical for selecting effective treatments and minimizing inappropriate antibiotic usage. For instance, COVID-19 underscored the need for robust diagnostic infrastructure to manage outbreaks and inform treatment protocols. Similarly, pneumonia remains a leading cause of mortality among children globally, particularly in low-income regions. AST helps clinicians identify suitable antimicrobials, thereby improving patient outcomes and reducing AMR risks. The growing dependence on AST for both routine and emergent infectious disease management continues to fuel market growth.

Key Market Challenges

Lack of Standardization and Validation

A major obstacle in the AST market is the absence of standardized procedures and validation protocols across different testing platforms and laboratories. The variation in testing methods can lead to inconsistent results, complicating clinical interpretation and undermining treatment efficacy. Without uniform guidelines, healthcare providers may struggle to compare susceptibility data across institutions or regions. The validation of new AST technologies is also resource-intensive, involving extensive trials to meet regulatory requirements. In developing regions, limited infrastructure and training further exacerbate the issue. These inconsistencies can delay adoption and hinder efforts to combat antimicrobial resistance effectively. Establishing global standards and robust validation processes is essential to address this challenge.

Key Market Trends

Shift Towards Automated and High-Throughput Systems

The global AST market is increasingly embracing automation and high-throughput platforms to meet rising diagnostic demand. Automated AST systems offer faster turnaround times, higher accuracy, and improved workflow efficiency, making them ideal for high-volume clinical settings. These systems reduce human error and enable large-scale sample processing, essential for timely identification of effective therapies. Integration with laboratory information systems (LIS) allows seamless data management and reporting. High-throughput capabilities are particularly critical as healthcare facilities face increasing caseloads due to infectious diseases and AMR. This trend toward automation is reshaping the diagnostic landscape, providing scalable, reliable solutions for modern healthcare environments.

Key Market Players

Bio-Rad Laboratories Inc.
Merck & Co., Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
bioMerieux SA
Becton, Dickinson and Company
ELITech Group SAS
F. Hoffmann-La Roche Ltd.
Accelerate Diagnostics, Inc.
HiMedia Laboratories Private Limited

Report Scope:

In this report, the Global Antimicrobial Susceptibility Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antimicrobial Susceptibility Testing Market, By Product:

Manual Tests
- MIC Strips
- Susceptibility Testing Disks
- Susceptibility Plates
Automated Instruments
Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

Automated AST
Etest Method
Dilution
Disk Diffusion
Others

Antimicrobial Susceptibility Testing Market, By Application:

Drug Development
Susceptibility Testing
Others

Antimicrobial Susceptibility Testing Market, By End User:

Hospitals
Diagnostic Laboratories
Biotechnology & Pharmaceutical Companies
Others

Antimicrobial Susceptibility Testing Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antimicrobial Susceptibility Testing Market.

Available Customizations:

Global Antimicrobial Susceptibility Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Manual Tests {MIC Strips, Susceptibility Testing Disks, Susceptibility Plates}, Automated Instruments, Consumables & Media)
- 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
- 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
- 5.2.4. By End User (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
5.3. Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Technique
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Technique
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End User
- 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Technique
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End User
- 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Technique
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Technique
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Technique
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End User
- 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Technique
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Technique
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Technique
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Technique
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Technique
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Technique
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End User
- 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Technique
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End User
- 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Technique
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End User
- 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Technique
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Technique
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Technique
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Technique
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End User
- 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Technique
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End User
- 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Technique
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Technique
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Technique
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Technique
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End User
- 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Technique
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Bio-Rad Laboratories Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Merck & Co., Inc.
14.3. Thermo Fisher Scientific Inc.
14.4. Danaher Corporation
14.5. bioMerieux SA
14.6. Becton, Dickinson and Company
14.7. ELITech Group SAS
14.8. F. Hoffmann-La Roche Ltd.
14.9. Accelerate Diagnostics, Inc.
14.10. HiMedia Laboratories Private Limited